The Business Times
SUBSCRIBERS

Drugmaker Takeda to zoom in on emerging markets

Published Wed, Feb 25, 2015 · 09:50 PM
Share this article.

Singapore

ASIA'S largest drugmaker Takeda Pharmaceutical has streamlined its Singapore operations in a move that reflects its focus on emerging markets.

Its new Biopolis office, costing an undisclosed sum, will now house its emerging-markets business unit headquarters that was previously based in Zurich, as well as its regional research and development centre and its vaccine business unit.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here